T1	p 234 235	.
T2	p 602 611	) scanner
T3	p 835 854	10 patients in each
T4	p 889 915	bilateral internal carotid
T5	p 925 926	(
T6	p 951 992	trunk , bilateral cavernous sinuses ( CSs
T7	i 6 21	Bolus injection
T8	i 25 33	contrast
T9	i 112 146	three-dimensional CT angiography :
T10	i 205 235	multidetector-row CT scanner .
T11	i 284 299	tomography ( CT
T12	i 396 405	injection
T13	i 522 556	three-dimensional CT angiography (
T14	i 572 613	a multidetector-row CT ( MDCT ) scanner .
T15	i 648 667	ml of iopamidol 300
T16	i 707 726	ml of iopamidol 300
T17	i 769 788	ml of iopamidol 370
T18	i 899 933	internal carotid arteries ( ICAs )
T19	i 936 943	basilar
T20	i 951 956	trunk
T21	i 969 978	cavernous
T22	i 1001 1008	Galenic
T23	i 1098 1110	four-channel
T24	i 1116 1117	.
T25	i 1299 1307	delivery
T26	i 1323 1351	the intermediate concentrate
T27	i 1432 1450	High-concentration
T28	o 61 94	concentrations and delivery rates
T29	o 161 173	intracranial
T30	o 328 349	intracranial arterial
T31	o 425 469	iodine delivery rate or higher concentration
T32	o 684 688	rate
T33	o 743 747	rate
T34	o 805 809	rate
T35	o 932 933	)
T36	o 936 950	basilar artery
T37	o 1009 1013	vein
T38	o 1116 1117	.
T39	o 1185 1233	iodine-delivery rate achieved good arteriovenous
T40	o 1292 1298	iodine
T41	o 1475 1490	ICA attenuation
T42	o 1499 1513	intracavernous
T43	o 1526 1530	gain